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ABSTRACT 23 
Streptococcus suis serotype 2 is an important swine bacterial pathogen and it is also an emerging 24 
zoonotic agent. It is unknown how S. suis virulent strains, which are usually found in low 25 
quantities in pig tonsils, manage to cross the first host defense lines to initiate systemic disease. 26 
Influenza virus produces a contagious infection in pigs which is frequently complicated by 27 
bacterial co-infections leading to significant economic impacts.  In this study, the effect of a 28 
preceding swine influenza H1N1 virus (swH1N1) infection of swine tracheal epithelial cells 29 
(NTPr) on the ability of S. suis serotype 2 to adhere, invade and activate these cells was 30 
evaluated. Cells pre-infected with swH1N1, showed bacterial adhesion and invasion levels 31 
increased more than 100 fold when compared to normal cells. Inhibition studies confirmed that 32 
the capsular sialic acid moiety is responsible for the binding to virus-infected cell surface. Also, 33 
pre-incubation of S. suis with swH1N1 significantly increased bacterial adhesion/invasion to 34 
epithelial cells, suggesting that S. suis may also use swH1N1 as a vehicle to invade epithelial 35 
cells when the two infections occur simultaneously. Influenza infection may facilitate the 36 
transient passage of S. suis at the respiratory tract to reach the bloodstream and cause bacteremia 37 
and septicemia. S. suis may also increase the local inflammation at the respiratory tract during 38 
influenza infection, as suggested by an exacerbated expression of pro-inflammatory mediators in 39 
co-infected cells. These results give a new insight in the elucidation of complex interactions 40 
between influenza virus and S. suis in a co-infection model. 41 
 42 
 43 
 44 
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INTRODUCTION 47 
 48 
Streptococcus suis is one of the most important post-weaning bacterial pathogens in swine and it 49 
is also an emerging zoonotic agent (1). Among the 35 S. suis described serotypes, type 2 is the 50 
most virulent one for both pigs and humans (2), although differences in virulence have been 51 
described for this serotype (3). Pigs may acquire S. suis very early in life and some colonized 52 
animals may never develop disease (carrier animals); on the other hand, some carrier piglets will 53 
eventually develop bacteremia, septicemia and meningitis following dissemination of S. suis in 54 
the bloodstream (1). Human infections with S. suis manifest mainly as meningitis, septicemia and 55 
septic shock (4). It is believed that people can become infected through skin lesions, surface 56 
mucosa and/or the oral route (5).  57 
It is still unknown how low quantities of S. suis virulent serotype 2 strains present in 58 
tonsils of pigs manages to cross the first natural line of the host defense to initiate disease. It is 59 
believed that the pathogen would breach the mucosal epithelium at the upper respiratory tract (6). 60 
Bacterial adhesion and invasion of epithelial cells are usually associated with the first steps of 61 
colonization by mucosal pathogens; however, few data are available concerning the interaction 62 
between S. suis and swine respiratory epithelial cells. Ferrando and colleagues described for the 63 
first time S. suis adhesion (but not invasion) to porcine tracheal epithelial cells (7).  64 
The S. suis capsular polysaccharide (CPS), which defines the serotype, is essential for the 65 
virulence of this pathogen mainly due to its antiphagocytic activity (6). The analysis of the 66 
serotype 2 CPS revealed the presence of different sugars including Neu5Ac or sialic acid. 67 
Interestingly, sialic acid was found to be terminal [(2→6)-β-D-Galactose], and the CPS can be 68 
quantitatively desialylated by mild acid hydrolysis (8). It has been previously shown that 69 
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expression of CPS interferes with adhesion and (if any) invasion of S. suis to epithelial cells (9, 70 
10). So, classically, the role of this virulence factor has been suggested to be crucial once bacteria 71 
reach the bloodstream (6). Among other suggested S. suis virulence factor, secreted proteins, such 72 
as the hemolysin (suilysin), surface proteins and other cell wall components have been reported 73 
(11). 74 
Secondary bacterial infections associated to influenza virus infection in humans are a 75 
leading cause of human morbidity and mortality worldwide (12). Swine influenza virus infections 76 
in pigs also cause serious respiratory disease (13). Although this infection is typically self-limited 77 
with high-morbidity but low mortality, secondary complications substantially increase illness and 78 
death (14). In fact, influenza is a key contributor to the porcine respiratory disease complex 79 
(PRDC), a multifactorial syndrome characterized by severe respiratory disease after infection 80 
with two or more agents (15). Pathogens associated with PRDC include (among others) 81 
Actinobacillus pleuropneumoniae, Haemophilus parasuis, Mycoplasma hyopneumoniae, S. suis 82 
and porcine reproductive and respiratory syndrome virus  (15). Subtypes of swine influenza virus 83 
that are most frequently identified in pigs include H1N1 (classical and pandemic), H1N2 and 84 
H3N2 (13). Influenza virus strains uniformly recognize cell surface oligosaccharides with a 85 
terminal sialic acid either 2,3 Neu5Ac–galactose or 2,6 Neu5Ac–galactose. However, their 86 
receptor specificity varies according to host. Pigs are unique among influenza virus hosts in that 87 
they are susceptible to infection with influenza viruses of human and avian origin as well as to 88 
swine influenza virus, because their tracheal epithelium contains these two sialyloligosaccharides 89 
(16). 90 
In this study we demonstrated, for the first time, a novel mechanism used by a bacterial 91 
species to facilitate the invasion of respiratory epithelial cells already infected with an influenza 92 
virus. More specifically, we showed that the sialic acid moiety present in the CPS of S. suis 93 
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serotype 2 directly interacts with swine influenza virus leading to an increased bacterial adhesion, 94 
invasion and activation of tracheal epithelial cells. This mechanism could explain, at least in part, 95 
how secondary bacterial infection with virulent S. suis strain could be enhanced following 96 
influenza infection. 97 
 98 
 99 
 100 
  101 
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MATERIALS AND METHODS 102 
 103 
Bacterial strains, epithelial cells and influenza virus strain. S. suis strains used in this study are 104 
listed in Table 1. The well characterized S. suis serotype 2 virulent strain 31533 (10, 17) was used 105 
throughout this study. Other previously well characterized isogenic mutants derived from this 106 
strain and devoid of either CPS or suilysin production, or modified at the either peptidoglycan 107 
(PG) or lipoteichoic acid (LTA) levels were also included (18-21). In addition, serotype 2 field 108 
strains with lower (Canadian strain) or higher (epidemic strain isolated from a deadly S. suis 109 
human outbreak in China) virulence potential (3), as well as reference strains of serotypes 3 and 110 
14 were also included for comparison purposes (Table 1). A swine influenza virus H1N1 111 
(swH1N1, strain A/swine/St-Hyacinthe/148/1990) isolated from a case of swine flu in Canada 112 
was used (22). 113 
Bacterial were cultured as previously reported (17). The number of CFU/ml in the final 114 
suspension before each experiment was determined by plating samples onto THA using 115 
Autoplate® 4000 Automated Spiral Plater (Spiral Biotech, Norwood, MA). The pig trachea 116 
epithelial cell line (NPTr) was used for virus growth and co-infection studies as described (23). 117 
For assays, cells were treated with 0.05% trypsin in 0.03% EDTA solution and diluted in culture 118 
medium to obtain a final concentration of 105 cells/ml. Then, the cell suspension was distributed 119 
into tissue culture plates and incubated until cell confluence was reached. Twenty-four hours 120 
before the assays, culture medium was removed from the wells and replaced by fresh complete 121 
medium without antibiotics. Virus was produced by replication in NPTr cells as previously 122 
described (23). The titer of the viral production was 107.25 TCID50/ml.  123 
 124 
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NPTr co-infection by swH1N1 and S. suis. swH1N1 (MOI: 1) was inoculated onto NPTr cell 125 
monolayers in 24-well culture plates and incubated with 2% FBS (as standardized in preliminary 126 
experiments) and antibiotic free MEM for 1 h at 37°C in 5% CO2. The virus-infected cells were 127 
then washed twice with PBS and fresh media containing 10% FBS without antibiotic was added. 128 
The increased serum concentration did not affect virus replication and kept cells healthy for the 129 
whole experiment. Following a 12 h incubation time at 37°C in 5% CO2, cells were infected with 130 
S. suis (106 CFU/well, MOI:10). Plates were centrifuged at 800 x g for 10 min in order to bring 131 
bacteria in close contact with the cells (24). Bacterial infected cells were then incubated at 37°C in 132 
5% CO2 for different incubation times (see below). Infectious viral load profile was determined in 133 
cell cultures for virus infected cells and for virus-bacteria co-infected cells by virus titration 134 
evaluation as described above. Cell cytotoxicity levels were determined using Cytotox 96 kit 135 
(Promega, Madison, WI) from culture supernatants according to manufacturer’s instruction. In 136 
selected experiments, swH1N1 and S. suis were pre-incubated for 1 h at 4°C (106 S. suis CFU and 137 
106 TCID50 of swH1N1, respectively; final bacteria/virus ratio of 1).   Afterwards, the virus-S. 138 
suis mixture was washed twice with PBS and resuspended with complete medium, inoculated to 139 
cells and incubated at 37°C in 5% CO2 for bacterial adhesion and invasion assays, as described 140 
below. Mock-treated bacteria were used as control.  141 
The invasion assay was performed as previously described (17), with some modifications. 142 
After 2 or 4 h of incubation with S. suis, the NPTr cells monolayers were washed twice with PBS, 143 
and 1 ml of cell culture medium containing 100 μg of gentamicin and 5 μg of penicillin G 144 
(Invitrogen, Burlington, ON, Canada) was added to each well. The plates were then further 145 
incubated for 1 h at 37°C with 5% CO2 to kill extracellular and surface-adherent bacteria. After 146 
washing, cells were disrupted with sterile ice-cold deionized water followed by cell scrapping 147 
from the bottom of the well in order to liberate intracellular bacteria. Bacterial CFU numbers were 148 
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determined by plating serial dilutions as described above. Levels of invasion were expressed as 149 
the total number of CFU recovered per well. An “adhesion assay” which in fact quantifies total 150 
cell-associated bacteria (intracellular bacteria and surface-adherent bacteria) was performed 151 
similarly to the invasion assay. However, the cells were vigorously washed five times to eliminate 152 
nonspecific bacterial attachment and no antibiotic treatment to kill the extracellular bacteria was 153 
used. At different incubation times (see results), the levels of “adhesion” (total associated 154 
bacteria) were expressed as the total number of CFU recovered per well.  155 
For the inhibition studies, and after removing the cell supernatant and washing twice the 156 
wells with fresh PBS, 100 µg of purified native CPS or desialylated CPS (prepared as described 157 
below) resuspended in cell culture medium were added to swH1N1-infected cells. Control cells 158 
were treated similarly but without addition of CPS. After 1 h of incubation, cells were washed 159 
twice with PBS and infected with S. suis as previously described. Bacterial adhesion and invasion 160 
studies were performed as described above and compared to non-treated cells. Results were 161 
expressed in percentage when compared to bacterial adhesion and invasion of untreated swH1N1 162 
pre-infected cells (considered as 100%). Swine polyclonal antibody serum against the whole 163 
swH1N1 virus strain (serum from a convalescent animal) was used a positive inhibition control. 164 
Supernatants of swH1N1-infected cells were removed and the serum (diluted 1/40 in cell culture 165 
medium) was added to the wells.  166 
 167 
Hemagglutination inhibition assay (HI). HI test was carried out as previously described (25) 168 
with the modification that swine sera were replaced by different concentrations of S. suis. Serial 169 
dilutions of S. suis strains (wild-type 31533 strain or non-encapsulated B218 mutant strain) were 170 
used for the HI assay.  Briefly, 50 μl of bacterial suspensions (grown as described above) were 171 
dispensed at different concentrations in triplicate in a 96-well round bottom plate. Fifty μl of 172 
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swH1N1 (2 x 106.25 TCID50/ml) was then added to each well and incubated for 1 h at room 173 
temperature. Different wells represented a 2-fold dilutions of S. suis/swH1N1virus ratios, 174 
beginning at a ratio of 200 for the wild type encapsulated strain and 10 000 for the non-175 
encapsulated B218 mutant. Afterward, 50 μl of a 0.5% suspension of whole rooster red blood 176 
cells (RBC) in PBS were added to each well and gently mixed. The HI was evaluated after 177 
incubating the plate at room temperature for 1 h. For this experiment, PBS was used as negative 178 
RBC control and serial dilutions of reference heat-inactivated anti-swH1N1 serum was used as a 179 
positive HI control. Under the conditions tested, capsulated and non-encapsulated S. suis strains 180 
did not induce any hemagglutination (results not shown). 181 
 182 
S. suis CPS purification and CPS desialylation. The CPS of S. suis serotype 2 reference strain 183 
S735 was prepared and purified as previously described (8). For quality controls, CPS was 184 
analyzed by nuclear magnetic resonance. Lack of protein and RNA/DNA contamination was 185 
verified by Lowry method and by spectrophotometry, respectively. CPS was also desialylated by 186 
mild acid hydrolysis. CPS (8 mg) was heated in 1 ml of HCl (70 mM) at 60 °C for 4 h, neutralized 187 
with NH4OH (2 M), and purified on a Sephadex G10 column (1.5 x 10 cm). Presence (native 188 
CPS) or absence (desialylated CPS) of sialic acid was verified by gas chromatography after 189 
methanolysis and acetylation and by nuclear magnetic resonance as well as by a reaction with an 190 
enzyme linked-lectin assay as previously described (26). 191 
 192 
Confocal and electron microscopy. For confocal microscopy analysis, cells were placed on 193 
coverslips and infected (or not) with swH1N1 and either S. suis strain 31533 or its non-194 
encapsulated mutant strain (B218) as described above and further incubated for 2 h at 37°C in 5% 195 
CO2. Coverslips were washed with PBS to remove non-associated bacteria and cells were fixed 196 
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with 4% paraformaldehyde solution for 10 min. Cells were then washed and permeabilized with 197 
PBS containing 0.2% Triton X-100 (Thermo Hyclone, Burlington, ON, Canada) for 2 min. The 198 
coverslips were blocked for 10 min with PBS containing 2% bovine serum albumin and 0.2% 199 
gelatin (Sigma-Aldrich, Oakville, ON, Canada). Coverslips were then incubated for 1 h with a 200 
mouse monoclonal antibody against an epitope within influenza virus A nucleoprotein H1N1 (US 201 
Biologica, Swampscott, MA l; 1/500 dilution) and a rabbit anti-S. suis serum against either wild-202 
type strain 31533 (1/5000) or its non-encapsulated B218 mutant strain (1/1000) (27). After 203 
washing with PBS, coverslips were incubated with secondary antibodies Alex-Fluor 568 goat 204 
anti-mouse IgG (for swH1N1) and Alex-Fluor 488 goat anti-rabbit IgG (for S. suis) (both from 205 
Invitrogen) for 30 min. Coverslips were then washed and mounted on glass slides with moviol 206 
containing DABCO. 207 
 For transmission electron microscopy (TEM) and scanning electron microscopy (SEM), 208 
samples were fixed for 1 h at room temperature with 2% (vol/vol) glutaraldehyde in 0.1 M 209 
cacodylate buffer (pH 7.3) and were then post-fixed for 45 min at room temperature with 2% 210 
osmium tetroxide. Specimens for TEM were dehydrated in a graded series of ethanol solutions 211 
and embedded with LR white resin. Thin sections were cut with a diamond knife and 212 
were poststained with uranyl acetate and lead citrate. Samples were observed with an electron 213 
microscope model JEM-1230 (JEOL, Tokyo, Japan). Samples for SEM were dehydrated in a 214 
graded series of ethanol solutions and covered with gold after critical point drying and were 215 
examined with a Hitachi S-3000N microscope. 216 
 217 
Quantitative RT-PCR (qRT-PCR) for cytokine and chemokine expression. qRT-PCR assay 218 
was performed as previously described (28). Primers (IDT DNA, Coralville, IA) used for 219 
detection of genes were all verified to have PCR amplification efficiency ranked between 90-220 
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110% using a CFX96 rapid thermal cycler system (Bio-Rad, Hercules, CA) (Table 2). The 221 
GeNorm applet v.3.5 (http://medgen.ugent.be/~jvdesomp/genorm/) was used to initially determine 222 
the two most stable reference genes from a set of six reference genes using random samples from 223 
the cDNA panel generated for the qPCR analysis of cytokine/chemokine gene expression. 224 
Therefore, normalization of data was done using the reference genes hypoxanthine 225 
phosphoribosyltransferase 1 (Hprt1) and Peptidylprolyl isomerase A (Ppia). Fold-change of gene 226 
expression was calculated using the normalized gene expression (ΔΔCq) calculation method of the 227 
CFX software manager v.2.1 (Bio-Rad). Mock-infected samples were used as calibrator and 228 
consequently, relative fold-differences were calculated for the rest of the samples compared to the 229 
mean of the calibrator samples. 230 
 231 
Statistical analysis. All data are expressed as mean ± SEM. Prism statistical software v.5 232 
(Graphpad, San Diego, CA) was employed for data analysis. Data from the adhesion and 233 
invasion assays were analyzed for significance using Student’s unpaired t -test. Data from qPCR 234 
assays were subjected to one way ANOVA analysis followed by Tukey’s post hoc test. A P value 235 
< 0.01 was used as threshold for statistical significance. Results reflect mean values of at least 236 
three independent experiments. 237 
 238 
  239 
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RESULTS 240 
 241 
S. suis serotype 2 adhesion and invasion are significantly increased when cells are 242 
previously infected by swH1N1, independently of the virulence of the S. suis strain. 243 
 The kinetics of adhesion of the highly virulent S. suis serotype 2 strain 31533 to NPTr 244 
cells was studied. As shown in Fig.1A, in the absence of virus infection, adhesion was time 245 
dependent, increasing from 30 min to 4 h of incubation. After 4 h of incubation, a plateau was 246 
reached (data not shown). Results of the kinetics and levels of adhesion are similar to those 247 
previously obtained with porcine endothelial and other epithelial cells (10, 17). However, when 248 
cells were pre-infected with swH1N1 for 12 h, the adhesion levels increased more than 100 folds 249 
compared to those observed in the absence of virus (Fig.1A). In addition, adhesion levels 250 
immediately reached a plateau (Fi.g 1A), even after 5 min of incubation (data not shown). When 251 
strains of serotype 2 with lower or higher virulence potential than that of 31533 strain were tested 252 
(intermediate virulence Canadian strain 1591 or epidemic strain SC84 from a Chinese human 253 
outbreak) (3), bacterial adhesion levels were statistically similar to those obtained with the 254 
virulent strain 31533, either in the absence or presence of swH1N1 infection (Fig. 2A). 255 
Surprisingly, and different from what has been previously reported with other epithelial 256 
cells of swine origin (10), encapsulated S. suis serotype 2 was able to clearly invade NPTr cells 257 
(Fig. 1B). However, when cells were pre-infected with the swH1N1 strain, invasion rates also 258 
increased more than 100 folds at both, 2 h and 4 h incubation times (P < 0.01) (Fig. 1B). Similar 259 
to the adhesion results, invasion rates of the two additional S. suis serotype 2 strains were 260 
statistically similar to those obtained with strain 31533 in the presence or absence of swH1N1 261 
pre-infection (Fig. 2B). For all adhesion and invasion experiments, cells presented cytotoxicity 262 
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levels lower than 20% (data not shown).  Interestingly, virus replication levels in NPTr cells were 263 
similar in the presence or absence of bacterial infection (Supplemental Fig. S1). 264 
 265 
Critical role of the capsular polysaccharide (CPS) in the increased S. suis adhesion/invasion 266 
to swH1N1 pre-infected NPTr cells. 267 
Isogenic mutants defective in suilysin production, D-alanylation of LTA or N-268 
deacetylation of PG behaved statistically similarly to the wild-type strain 31533 either in the 269 
presence or absence of swH1N1 pre-infection. Only the non-encapsulated (CPS-) mutant 270 
presented a different pattern. In the absence of virus infection, the adhesion and invasion levels of 271 
the mutant strain were significantly higher (P < 0.01) than those of the wild-type strain (Fig. 2A 272 
and 2B), confirming previous published results which indicated that the CPS interferes with S. 273 
suis-host cell interactions (9, 10). However, these adhesion and invasion levels were unmodified 274 
after a swH1N1 pre-infection. These data suggest that the CPS might play a role in the observed 275 
increased levels of wild-type S. suis adhesion/invasion to virus infected cells (Fig. 2A and 2B). 276 
Since the antigenic characteristics of the CPS define the serotype (1), two additional S. suis 277 
serotypes (3 and 14) were tested. Although both strains are well encapsulated (29), only the 278 
adhesion and invasion of S. suis serotype 14 reference strain (DAN13730), but not those of 279 
serotype 3 (strain 4961), were significantly affected by a pre-infection with swH1N1 (Fig. 2A 280 
and 2B). This would indicate that the CPS structure and/or composition directly influence the 281 
interactions between S. suis and swH1N1 pre-infected cells.  282 
Influence of epithelial cell swH1N1 pre-infection on adhesion/invasion abilities of S. suis 283 
serotype 2 was confirmed by microscopy. First, confocal microscopy revealed that very few 284 
encapsulated wild-type bacteria could be observed interacting with epithelial cells in the absence 285 
of virus pre-infection (Fig. 3). However, after 12 h of swH1N1 pre-infection, levels of wild-type 286 
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encapsulated S. suis adhesion were clearly higher and grouped around the cells (in “grapes”), 287 
especially where the red staining with anti-H1N1 monoclonal antibody was present, indicating a 288 
possible co-localization of virus and bacteria. In the absence of virus infection, the non-289 
encapsulated mutant showed a higher level of adhesion than the wild-type strain, although 290 
bacteria were randomly distributed on the cell surface (diffuse adhesion). A similar adhesion 291 
pattern of the mutant strain was observed when cells were pre-infected with swH1N1. Electron 292 
microscopy (TEM and SEM) confirmed the influence of a pre-infection with influenza virus on S. 293 
suis-cell interactions (Fig. 4). In the absence of virus infection, very few cocci (if any) could be 294 
observed interacting with cells (Fig. 4A-I). In the presence of a virus pre-infection, cells were 295 
highly activated (clearly showing cilia at their surface) and high numbers of cocci were at the cell 296 
surface (closely interacting with cilia) (Fig. 4AII and 4B) and, sometimes, inside the cells (Fig. 4 297 
AIII).  298 
 299 
Bacterial capsular sialic acid is responsible for bacterial-virus interactions in infected cells.  300 
Since the CPS of S. suis serotype 2 was shown to be implicated in the increased bacterial-301 
cell interactions when cells were pre-infected with swH1N1, it was hypothesized that the sialic 302 
acid moiety present in the CPS of this serotype may be involved through interactions with viral 303 
hemagglutinin.  In fact, the reference strain of serotype 14 CPS (which also interacted with 304 
swH1N1 pre-infected cells) possesses an identical sialic acid-containing side chain (also with a 305 
link 2,6 to the adjacent galactose) as serotype 2 CPS (30), whereas the reference strain of 306 
serotype 3 lacks this sugar (31-33). To confirm such hypothesis, inhibition studies were 307 
performed. Interestingly, when wells were simply washed before adding the bacterial suspension 308 
and used as a control, no differences could be obtained with previous results with non-washed 309 
wells, indicating that free virus were either not present at significant number or that they did not 310 
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significantly interfere with baceterial adhesion/invasion to epithelial cells. A pre-treatment of 311 
swH1N1-NPTr pre-infected cells with purified native CPS inhibits >75% of adhesion and 312 
invasion by S. suis serotype 2. This inhibition was similar to that obtained with a pre-treatment 313 
with an anti-swH1N1 specific antibody (Fig. 5). When the same amount of desialylated CPS was 314 
used, no inhibition of bacterial adhesion/invasion could be observed, confirming the involvement 315 
of the CPS sialic acid in the interactions of S. suis with swH1N1 pre-infected cells (Fig. 5).  316 
 317 
In vitro binding of swH1N1 to S. suis enhances bacterial adhesion and invasion to epithelial 318 
cells.  319 
To investigate if well encapsulated S. suis may directly interact with the swH1N1 strain, a 320 
test of hemagglutination inhibition was performed. Results showed that a 1 h pre-incubation of S. 321 
suis serotype 2 strain 31533 and swH1N1 virus (in a bacteria/virus ratio >50) resulted in the 322 
complete inhibition of RBC hemagglutination (Supplemental figure 2). Lower concentrations of 323 
bacteria did not present any visual inhibition. Interestingly, no inhibition of RBC 324 
hemagglutination was observed when the non-encapsulated mutant was used, even in a 325 
bacteria/virus ratio of 10 000) (Supplemental figure 2). Finally, a pre-incubation of S. suis 326 
serotype 2 strain 31533 with the swH1N1 strain significantly increase the interaction between S. 327 
suis and NPTr cells, since bacterial adhesion and invasion to epithelial cells presented up to 10 328 
fold increase values when compared to those infected with S. suis without a pre-incubation with 329 
swH1N1 (Fig. 6). These results suggest that S. suis may also use swH1N1 virus as a vehicle to 330 
adhere and invade epithelial cells. The fact that some bacteria may aggregate with virus (forming 331 
micro-clumps) enhancing somehow the total number of bacterial adhesion to cells cannot be 332 
ruled out. No increase in bacteria-cell interactions was observed when the non-encapsulated 333 
mutant was used (data not shown).  334 
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 335 
Co-infected NPTr cells express higher levels of pro-inflammatory genes than single-infected 336 
cells.  337 
 Although a complete kinetics was studied (results not shown), results showed that 24 h 338 
post-bacterial infection (36 h post virus infection) reflected optimal differences among groups. 339 
NPTr cells infected with bacteria alone showed absence or low expression levels of CCL2 (MCP-340 
1), CCL4 (MIP-1β), IFN-β and TNF-α, intermediate expression levels of IL-6 and high levels of 341 
IL-8 expression (Fig. 7). Virus-mediated NPTr cell activation at that incubation time showed 342 
absence of IL-8 expression.  On the other hand, the swH1N1 strain activated gene expression of 343 
other mediators at similar levels (CCL2 and IL-6) or at significantly higher levels (CCL4, TNF-α 344 
and IFN-β) than those obtained after activation with S. suis alone (Fig. 7). Interestingly, 345 
swH1N1-S. suis co-infection significantly increased the expression of CCL2, CCL4, IL-6, IL-8 346 
and TNF-α mRNA. In some cases, an additive effect seemed responsible for such differences (IL-347 
6 and TNF-α). However, the increase of mRNA expression of CCL2, CCL4 and IL-8 mRNA 348 
expression was clearly ahead of a simple additive effect.  Expression of IFN-β mRNA was 349 
probably attributed solely to the effect of swH1N1 (Fig. 7).  350 
  351 
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DISCUSSION 352 
The pathogenesis of the infection caused by S. suis is far from being completely 353 
understood (6). In swine, S. suis is mainly transmitted by aerosols, and airborne transmission 354 
among pigs has been clearly demonstrated (34). S. suis play a certain role in mixed respiratory 355 
infections, although it is not considered a primary cause of swine pneumonia (1), indicating that 356 
it may also use the respiratory tract as a transient passage before reaching the bloodstream and 357 
causing bacteremia, which is essential for the pathogen to cause meningitis (35). The actual early 358 
mechanisms used by this pathogen to interact with epithelial cells to further invade the 359 
bloodstream are, in fact, poorly known.  360 
S. suis clinical association with virus infections have been largely reported (36, 37). More 361 
recently, several outbreaks in swine due to swine influenza virus with a significant level of 362 
systemic co-infection due to S. suis have been reported in England (38). In humans, it is well 363 
known that influenza cases are heavily complicated by bacterial infections (12). In fact, it has 364 
been previously reported that influenza as well as other respiratory virus increase the 365 
adhesion/invasion capacities of bacterial pathogens (including streptococci) to epithelial cells, 366 
although mechanisms have not been fully elucidated (39). The goal of the present work was to 367 
study interactions between S. suis and tracheal epithelial cells either pre-infected or not with 368 
swH1N1. 369 
Results showed that S. suis is able to not only to adhere to but also invade swine tracheal 370 
epithelial cells. In the absence of virus infections, adhesins involved in such interactions seem to 371 
be located in the bacterial cell wall, since they are hindered by the presence of the CPS, as 372 
previously suggested (6, 9, 10). Indeed, significant higher levels of adhesion and, most important, 373 
invasion rates were observed with a non-encapsulated S. suis mutant. Interestingly, results 374 
obtained with isogenic mutants showed that alteration at the LTA and PG as well as the lack of 375 
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suilysin production did not influence the adhesion/invasion capacities of S. suis. Different S. suis 376 
surface-exposed proteins have been described as bacterial adhesins to extracellular matrix 377 
proteins present in host cells (6, 11). In fact, ApuA, a surface protein with bifunctional 378 
amylopullulanase activity, was described to play an important role in such adhesion to tracheal 379 
epithelial cells (7). No differences could also be observed between strains of serotype 2 of 380 
difference virulence potential or strains belonging to other serotypes showing that those adhesins 381 
are probably common to most strains of S. suis, independently of their virulence/serotype.  382 
In the presence of a prior swH1N1 infection, more than 100 fold increases in S. suis 383 
adhesion and invasion could be observed. This increased interaction was confirmed by confocal, 384 
TEM and SEM. Increased cell susceptibility to S. suis adhesion and invasion following a virus 385 
infection may have different explanations.  One of the most well-known interactions is that 386 
between influenza virus and Streptococcus pneumoniae (40). In vivo increased susceptibility has 387 
been attributed to an alteration of anti-bacterial phagocyte functions through a diminished 388 
bactericidal activity and/or damage to the respiratory epithelium resulting in defective 389 
mucociliary clearance mechanisms, which in turn leads to an increased numbers of bacteria that 390 
remains in the respiratory tract (41). In vitro studies suggested damage to the respiratory 391 
epithelium by exposing surface molecules and cell receptors to which pneumococci more readily 392 
adhere and invade cells. This effect would be mainly done by the viral neuraminidase (42), 393 
although a certain synergistic role of neuraminidase produced by S. pneumoniae cannot be rule 394 
out (43).  395 
Results from the present study indicate that interactions between influenza virus and S. 396 
suis are clearly different from those with S. pneumoniae. In fact, no neuraminidase activities have 397 
been so far demonstrated for S. suis. On the other hand, a clear role of the surface exposed CPS in 398 
the S. suis interactions with swH1N1-infected cells could be established. Similar results were 399 
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previously obtained with Group A Streptococcus (GAS) and A549 epithelial cells (44). Although 400 
a certain direct binding between GAS and influenza virus could be observed, molecules involved 401 
in such interactions have so far not been elucidated (45). Interestingly, GAS lacks sialic-acid in 402 
its surface. In the present study, the main serotypes of S. suis containing sialic acid (serotypes 2 403 
and 14) clearly interact with swH1N1-infected cells, whereas interactions of a serotype lacking 404 
this sugar (serotype 3) were not affected by a virus pre-infection. In addition, serotype 2 strains of 405 
different virulence potential behaved similarly, due to the fact that capsular composition of the 406 
three strains is most probably identical. In an inhibition assay using highly purified native and 407 
desialylated CPS purified from the reference strain of serotype 2, it was clearly showed that the 408 
bacterial sialic acid moiety was responsible for the virus-bacterial interactions. It was then 409 
hypothesized that the S. suis sialic acid binds to the hemagglutinin of the swH1N1. This was 410 
further demonstrated by the fact that well-encapsulated S. suis (but not its non-encapsulated 411 
mutant) incubated with the swH1N1 strain was able to inhibit the RBC hemagglutination activity 412 
of the virus. The binding of S. suis CPS to influenza hemagglutinin was not exclusive of the 413 
H1N1 strain used. Another swine influenza field strain (H3N2) used in parallel studies offered 414 
identical results than those obtained with the H1N1 strain (unpublished observations). 415 
Interestingly, direct binding of Group B Streptococcus (GBS) to influenza virus has also been 416 
described previously (46). It was hypothesized that the sialyl-galactose linkage in GBS was 417 
responsible for binding to the virus (46). We suggest that GBS would behave similarly to S. suis 418 
since the structures of the CPS of both pathogens are similar (8). Interestingly, not all bacterial 419 
pathogens possessing capsular sialic acid use a similar mechanism. For example, it has been 420 
proposed that a direct interaction between the neuraminidase of influenza virus and the CPS of 421 
Neisseria meningitidis enhances bacterial adhesion to cultured epithelial cells, most likely 422 
through cleavage of capsular sialic acid-containing bacterial polysaccharides (47). 423 
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 Although a typical pre-infection with influenza virus is believed to be followed by a 424 
bacterial complication, a simultaneous infection with both pathogens cannot be disregarded. In 425 
pigs, for example, both pathogens may infect animals at the same age range (1). In this study, a 426 
binding between free S. suis serotype 2 to free swH1N1 promotes enhanced bacterial adhesion 427 
and invasion to swine epithelial cells, similarly to what has been shown for GAS (45).   Similarly, 428 
previous in vitro binding of non-identified surface exposed proteins of Staphylococcus aureus to 429 
the viral hemoagglutinin enhances bacterial invasion to virus-uninfected cells (48). Hence, 430 
influenza infection may promote adhesion and internalization of S. suis not only by binding of 431 
bacteria to the membrane-associated hemagglutinin but also by binding of bacteria to free virions 432 
followed by internalization of virus-coated bacteria into non-infected epithelial cells. Therefore, a 433 
possible synergy between the two pathogens cannot be ruled out. However, further studies on the 434 
exact mechanisms involved should be performed. 435 
 Influenza virus is able to stimulate epithelial cells and induce the over-production of 436 
different inflammatory mediators. In addition, it may directly or indirectly interfere with the 437 
balance of cytokine/chemokine production (49).  In co-infection studies, activation of epithelial 438 
cells by influenza virus enhances the induction of cytokine and chemokine gene transcripts by S. 439 
pneumoniae (50). Inflammation has been reported to be highly important in S. suis infections 440 
(51). So far, the inflammatory response of respiratory epithelial cells generated by S. suis has not 441 
been addressed. In the present study, S. suis was shown to strongly up-regulate gene expression 442 
of mainly IL-6 and IL-8, similar to that observed with epithelial cells of the choroid plexus (52). 443 
Differently from what was described with these cells, relatively low levels of TNF-α expression 444 
were observed with S. suis-activated NPTr cells, even at shorter incubation times (data not 445 
shown), indicating some differences between the two cell types. When NPTr cells were pre-446 
infected with swH1N1, the significant increase of IL-8 expression that was observed may be 447 
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explained by a higher number of bacteria interacting with influenza-infected cells. It has been 448 
shown that IL-8 expression by S. suis-activated endothelial cells is bacterial-concentration 449 
dependent (53). In the case of IL-6 and TNF-α, the increased expression observed under the co-450 
infection conditions may be also explained by an additive effect of swH1N1 and S. suis. On the 451 
other hand, S. suis alone did not produce significant levels of CCL2 and CCL4.  However, when 452 
cells were pre-infected with swH1N1, between 100 and 300 fold increases in mRNA expression 453 
of these mediators were detected.  Influenza virus replicates in the respiratory epithelium and 454 
induces an inflammatory infiltrate comprised of mononuclear cells and neutrophils (54), to which 455 
S. suis possesses anti-phagocytic capacities (6). Since S. suis is not a primary pulmonary 456 
pathogen, an exacerbated production of pro-inflammatory mediators during a co-infection with 457 
influenza virus may be important in the pathogenesis of the influenza infection.  458 
 In conclusion, a new role of S. suis CPS, other than that of anti-phagocytic factor (55), has 459 
been demonstrated in the present study. Although it was previously reported that the presence of 460 
sialic acid in S. suis could not be directly related to virulence (56), we demonstrated that its 461 
presence plays a major role in the interactions with respiratory epithelial cells previously infected 462 
by swine influenza virus, acting as a bacterial receptor for the virus. Simultaneous co-infections 463 
with both pathogens may also be mutually beneficial due to direct bacterial-virus interaction. 464 
Binding of bacteria to influenza virus-infected cells or directly to influenza virus could play an 465 
important role allowing bacteria to move towards the lower airways, initiating the systemic 466 
invasion that characterizes the pathogenesis of the infection caused by S. suis. The increased 467 
production of local pro-inflammatory mediators in the presence of both pathogens may also play 468 
an important role in the pathogenesis of the pneumonia caused by swine influenza.  469 
 470 
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TABLE 1  List of Streptococcus suis strains used in this study 
Strains Relevant phenotype and/or description References 
31533 Serotype 2 highly pathogenic European strain isolated from a disease pig 
(10) 
SC84 Serotype 2 epidemic virulent strain isolated from a human outbreak in  China 
(3) 
89-1591 Serotype 2 iintermediate virulent strain isolated from a disease pig in Canada 
(3) 
CPS-  Non-encapsulated B218 mutant strain derived from strain 31533 (19) 
∆Sly  Suilysin negative SX911 mutant strain derived from strain 31533 (18) 
∆dLTA  D-alanylation of LTA mutant strain derived from strain 31533 (20) 
∆pgdA  
 
N-deacetylation of peptidoglycan mutant strain derived from strain 
31533 
 
(21) 
4961 Reference strain, serotype 3, isolated from a diseased pig (57) 
DAN13730 Reference strain, serotype 14 isolated from a diseased human (57) 
S735 Reference strain, serotype 2, isolated from a diseased pig (8) 
 
 
TABLE 2 Sequences of porcine-specific real-time PCR primers 
Gene Genebank ID Amplicon size Forward Sequence Reverse Sequence 
Efficiency 
(qPCR) 
Hprt1 NM_001032376 142 bp GCAGCCCCAGCGTCGTGATT CGAGCAAGCCGTTCAGTCCTGT 99 
Ppia NM_214353 133 bp TGCAGACAAAGTTCCAAAGACAG GCCACCAGTGCCATTATGG 97 
Ccl2 NM_214214 169 bp CAGGTCCTTGCCCAGCCAGATG CACAGATCTCCTTGCCCGCGA 90 
Ccl4 NM_213779 125 bp TCCCACCTCCTGCTGCTTCACAT GCCTGCCCTTTTTGGTCTGGAA 100 
Il6 NM_214399 105 bp ACTCCCTCTCCACAAGCGCCTT TGGCATCTTCTTCCAGGCGTCCC 97 
Il8 NW_003300390 80 bp TGTGAGGCTGCAGTTCTGGCAAG GGGTGGAAAGGTGTGGAATGCGT 95 
Ifnβ NM_001003923.1 150 bp TGCAACCACCACAATTCCAGAAGG TCTGCCCATCAAGTTCCACAAGGA 96 
Tnf NM_214022 112 bp GCCACCACGCTCTTCTGCCTA ACGATGATCTGAGTCCTTGGGCCA 91 
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FIGURE LEGENDS 
FIG 1. Adhesion to and invasion of virus-free or swH1N1-infected NPTr cells by S. suis 
serotype 2 strain 31533. NPTr cells were either pre-infected with swH1N1 for 12 h (MOI: 1) or 
not, and subsequently infected with S. suis serotype 2 strain 31533 (MOI: 10). (A) Kinetics of 
adhesion of S. suis to virus-infected (“V+B”) or control (“B”) NPTr cells. After S. suis infection 
cells were extensively washed to remove non-adherent bacteria and then lysed to determine S. suis 
viable counts. (B) S. suis invasion of swH1N1-infected (“V+B”) or control (“B”) NPTr cells at 2 
and 4 h bacterial incubation times. Results were determined as described above except that after 
washing, cells were exposed to antibiotics to kill extracellular bacteria. Data are expressed as mean 
± SEM of at least four independent experiments, each done in triplicate. * indicates significant 
difference between samples infected with bacteria alone and those co-infected with virus and 
bacteria (P < 0.01). 
 
FIG 2. Adhesion to and invasion of virus free or swH1N1-infected NPTr cells by different 
strains of S. suis. NPTr cells were either pre-infected with swH1N1 for 12 h (MOI: 1) or not, 
and subsequently infected with S. suis strains (MOI: 10). (A) Adhesion (incubation time of 2 h) 
of different S. suis strains to NPTr cells. Results were determined after exposure of swH1N1-
infected (“V+B”) or control (“B”) NPTr cells to S. suis, followed by extensive washing of non-
adherent bacteria and cell lysis to obtain S. suis viable counts. (B) Invasion (incubation time of 1 
h) of swH1N1-infected (“V+B”) or control (“B”) NPTr cells by different S. suis strains. Results 
were determined as described above except that after washing, cells were exposed to antibiotics to 
kill extracellular bacteria. See Table 1 for strain description. Data are expressed as mean ± SEM of 
at least four independent experiments, each done in triplicate. * indicates significant difference 
between samples infected with bacteria alone and those co-infected with virus and bacteria (P < 
0.01). 
 
FIG 3. Confocal microscopy showing association of wild-type encapsulated S. suis serotype 2 
strain 31533 and its non-encapsulated mutant (CPS-) with virus free cells (control) or 
swH1N1 pre-infected NPTr cells. Cells were non-infected (control) or virus-infected for 12 h 
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with swH1N1 (MOI: 1) and then infected with either S. suis wild-type strain or the CPS- mutant 
strain (MOI: 10) for 2 h. Samples were labeled using polyclonal antibodies conjugated with Alexa 
Fluor 488 against S. suis (green) and a mouse monoclonal antibody against influenza virus A 
nucleoprotein H1N1 conjugated with Alexa Fluor 568 against swH1N1 (red).  (A) Wild type S. 
suis strain 31533 shows high level of interactions with cells only when pre-infected with swH1N1. 
Non-encapsulated S. suis/cell interaction is not altered by a pre-infection with influenza virus. (B) 
High adhesion/invasion of S. suis strain 31533 to swH1N1 pre-infected cells. Scale bar, 10 μm 
Original magnification 100X. 
 
FIG 4. Transmission (TEM) and scanning (SEM) electron microscopy showing interactions 
between S. suis serotype 2 and NTPr cells. (A-I) TEM micrograph of S. suis serotype 2 strain 
31533 infection of virus free (control) NPTr cells showing very few cocci at the cell surface. (A-II 
and A-III) TEM micrographs of S. suis strain 31533 infection of swH1N1 pre-infected NPTr cells 
showing high numbers of cocci interacting with epithelial cells (A-II) and also intracellular 
bacteria (A-III). Scale bar, 1 μm. Original magnification, 5000x. (B) SEM micrograph of S. suis 
serotype 2 strain 31533 infection of swH1N1 pre-infected NPTr cells showing high numbers of 
cocci intimately interacting with cell cilia. Scale bar, 1 μm. Original magnification, 10 000x. No 
bacteria could be found in all observed SEM fields of control NPTr cells infected with S. suis 
strain 31533 only (data not shown). Black arrows show bacterial cells and arrow heads show cilia. 
CM: cell membrane.  
 
FIG 5. S. suis native, but not desialylated,  capsular polysaccharide (CPS), inhibits S. suis 
adhesion to (A) and invasion of (B) of NPTr cells pre-infected with swH1N1. NPTr cells were 
infected with swH1N1 (MOI: 1) for 12 h and then incubated with the native CPS (100 µg/well) 
desialylated CPS (100 µg/well), or a polyclonal antibody serum against SIV H1N1 (1/40 dilution, 
positive control) for 1 h at 37°C.  S. suis strain 31533 (MOI: 10) was then added to pre-treated 
NPTr cells. Two hours post-infection, adhesion and invasion of S. suis was assessed as described 
in Materials and Methods. Results are expressed in percentage when compared to bacterial 
adhesion and invasion of untreated swH1N1 pre-infected cells (considered as 100%). Data are 
29 
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expressed as mean ± SEM of at least three independent experiments. Groups that are significantly 
different from each other are indicated by different letters (a and b), as determined by One-way 
ANOVA with P ≤ 0.01. 
 
FIG 6. Pre-incubation of S. suis and swH1N1 significantly increases bacterial adhesion to 
and invasion of NPTr cells. swH1N1 and S. suis serotype 2 strain 31533 (1:1 ratio; TCID50: 
CFU) were pre-incubated for 1 h at 4° C. This mixture (“V+B”) was was then added to NPTr cells 
for an incubation time of 1 h or 2 h for adhesion/invasion assays, respectively, as described in 
Materials and Methods. Mock-treated bacteria were used as control (“B”). Data are expressed as 
mean ± SEM of at least three independent experiments. * indicates significant differences (P < 
0.01). 
 
FIG 7. Gene expression of pro-inflammatory mediators by NPTr cells. NPTr cells were 
either pre-infected with swH1N1 for 12 h (MOI: 1) or not, and subsequently infected with S. 
suis serotype 2 strain 31533 (MOI: 10) for 24 h. Total RNA was extracted from S. suis and virus 
co-infected cells (“V+B”), virus single-infected cells (“V”) or bacteria single-infected cells (“B”) 
and quantitative PCR analysis of selected genes was performed. Normalization of the data was 
done using the reference genes Hprt1 and Ppia. Mock non-infected samples were used as 
calibrator and consequently, relative fold-differences were calculated for the rest of the samples 
compared to the mean of the calibrator samples. Data represent mean values ± SEM of relative 
fold expression. Groups that are significantly different from each other are indicated by different 
letters (a, b, and c), as determined by One-way ANOVA with P ≤ 0.01. 
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FIG 1 Adhesion to and invasion of virus-free or swH1N1-infected NPTr cells by S. suis serotype
2 strain 31533. NPTr cells were either pre-infected with swH1N1 for 12 h (MOI: 1) or not, and
subsequently infected with S. suis serotype 2 strain 31533 (MOI: 10). (A) Kinetics of adhesion
of S. suis to virus-infected (“V+B”) or control (“B”) NPTr cells. After S. suis infection cells
were extensively washed to remove non-adherent bacteria and then lysed to determine S. suis
viable counts. (B) S. suis invasion of swH1N1-infected (“V+B”) or control (“B”) NPTr cells at 2
and 4 h bacterial incubation times. Results were determined as described above except that after
washing, cells were exposed to antibiotics to kill extracellular bacteria. Data are expressed as
mean ± SEM of at least four independent experiments, each done in triplicate. * indicates
significant difference between samples infected with bacteria alone and those co-infected with
virus and bacteria (P < 0.01).
AB
FIG 2 Adhesion to and invasion of virus free or swH1N1-infected NPTr cells by different strains
of S. suis. NPTr cells were either pre-infected with swH1N1 for 12 h (MOI: 1) or not, and
subsequently infected with S. suis strains (MOI: 10). (A) Adhesion (incubation time of 2 h) of
different S. suis strains to NPTr cells. Results were determined after exposure of swH1N1-
infected (“V+B”) or control (“B”) NPTr cells to S. suis, followed by extensive washing of non-
adherent bacteria and cell lysis to obtain S. suis viable counts. (B) Invasion (incubation time of 1h)
of swH1N1-infected (“V+B”) or control (“B”) NPTr cells by different S. suis strains. Results
were determined as described above except that after washing, cells were exposed to antibiotics
to kill extracellular bacteria. See Table 1 for strain description. Data are expressed as mean ±
SEM of at least four independent experiments, each done in triplicate. * indicates significant
difference between samples infected with bacteria alone and those co-infected with virus and
bacteria (P < 0.01).
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FIG 3 Increased interactions of S. suis serotype 2 with NPTr cells pre-infected with
swH1N1 virus: Role of the capsular polysaccharide. Confocal microscopy showing
association of wild-type encapsulated S. suis serotype 2 strain 31533 or its non-
encapsulated mutant (CPS-) with virus free cells (control) or swH1N1 pre-infected
NPTr cells. Cells were non-infected (control) or virus-infected for 12 h with swH1N1
(MOI: 1) and then infected with either S. suis wild-type strain or the CPS- mutant strain
(MOI: 10) for 2 h. Samples were labeled using antibodies conjugated with Alexa Fluor
488 against S. suis (green) and antibodies conjugated with Alexa Fluor 568 against
swH1N1 (red). Original magnification 100X.
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FIG 4 Transmission (TEM) and scanning (SEM) electron microscopy showing interactions
between S. suis serotype 2 and NTPr cells. NPTr cells were either pre-infected with swH1N1
for 12 h (MOI: 1) or not, and subsequently infected with S. suis serotype 2 strain 31533
(MOI: 10). (A-I) TEM micrograph of S. suis serotype 2 strain 31533 infection (incubation
time of 1h) of virus free (control) NPTr cells showing very few cocci at the cell surface.
Scale bar, 1 μm. Original magnification, 5000x. (A-II) TEM micrograph of S. suis strain
31533 infection of swH1N1 pre-infected NPTr cells showing high numbers of cocci
interacting with epithelial cells. Scale bar, 1 μm. Original magnification, 5000x. (B) SEM
micrograph of S. suis serotype 2 strain 31533 infection (incubation time of 1h) of swH1N1
pre-infected NPTr cells showing high numbers of cocci intimately interacting with cell cilia.
Scale bar, 1 μm. Original magnification, 10 000x. No bacteria could be found in all observed
SEM fields of control NPTr cells infected with S. suis strain 31533 only (data not shown).
Arrows show bacterial cells.
FIG 5 S. suis native, but not desialylated, capsular polysaccharide (CPS), inhibits S. suis adhesion
to (A) and invasion of (B) of NPTr cells pre-infected with swH1N1. NPTr cells were infected with
swH1N1 (MOI: 1) for 12 h and then incubated with the native CPS (100 μg/well) desialylated CPS
(100 μg/well), or a polyclonal antibody serum against SIV H1N1 (1/40 dilution, positive control) for
1 h at 37°C. S. suis strain 31533 (MOI: 10) was then added to pre-treated NPTr cells. Two hours
post-infection, adhesion and invasion of S. suis was assessed as described in Materials and Methods.
Results are expressed in percentage when compared to bacterial adhesion and invasion of untreated
swH1N1 pre-infected cells (considered as 100%). Data are expressed as mean ± SEM of at least
three independent experiments. Groups that are significantly different are indicated by letters (a and
b), as determined by One-way ANOVA with P ≤ 0.01.
A B
a
b b
a a
b
a
0
20
40
60
80
100
S.
 s
ui
s 
ad
he
si
on
 (%
)
0
20
40
60
80
100
S.
 s
ui
s 
in
va
si
on
 (%
)
b
V + B B
100
101
102
103
104
105 *
S.
 s
ui
s 
ad
he
si
on
(C
FU
 re
co
ve
re
d/
w
el
l)
V + B B
100
101
102
103
104
105
*
S.
 s
ui
s 
in
va
si
on
(C
FU
 re
co
ve
re
d/
w
el
l)
FIG 6 Pre-incubation of S. suis and swH1N1 significantly increases bacterial adhesion to and invasion
of NPTr cells. swH1N1 and S. suis serotype 2 strain 31533 (1:1 ratio; TCID50: CFU) were pre-
incubated for 1 h at 4°C. This mixture (“V + B”) was then added to NPTr cells for an incubation
time of 1 h or 2 h for adhesion/invasion assays, respectively, as described in Materials and Methods.
Mock-treated bacteria were used as control (“B”). Data are expressed as mean ± SEM of at least
three independent experiments. * indicates significant differences (P< 0.01).
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FIG 7 Gene expression of pro-inflammatory mediators by NPTr cells. NPTr cells were
either pre-infected with swH1N1 for 12 h (MOI: 1) or not, and subsequently infected
with S. suis serotype 2 strain 31533 (MOI: 10) for 24 h. Total RNA was extracted from S.
suis and virus co-infected cells (“V+B”), virus single-infected cells (“V”) or bacteria
single-infected cells (“B”), and quantitative PCR analysis of selected genes was
performed. Normalization of the data was done using the reference genes Hprt1 and
Ppia. Mock non-infected samples were used as calibrator and consequently, relative
fold-differences were calculated for the rest of the samples compared to the mean of the
calibrator samples. Data represent mean values ± SEM of relative fold expression.
Groups that are significantly different are indicated by letters (a, b, and c), as
determined by One-way ANOVA with P ≤ 0.01.
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